Springer Nature
Clinical Research in Cardiology Supplements
,  volume 12 ,  issue S1 ,  pages 22-26

Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)

P. Grützmacher 1
, 
B Öhm 1
, 
S Szymczak 1
, 
C. Dorbath 1
, 
M. Brzoska 1
, 
C. Kleinert 1
1
 
2nd Medical Clinic – Nephrology, Hypertension and Vascular Diseases, AGAPLESION Markus-Hospital, Frankfurt/Main, Germany | 
Publication type: Journal Article
Publication date: 2017-02-23
Springer Nature
SJR: —
CiteScore: —
Impact factor: —
ISSN: 18610706, 18610714
Molecular Biology
General Medicine
Structural Biology
Radiology, Nuclear Medicine and imaging
Abstract
General lipoprotein (Lp) (a) screening can help to identify patients at high risk for cardiovascular disease. Non-invasive methods allow early detection of clinically asymptomatic incipient atherosclerotic disease. Medical treatment options are still unsatisfactory. Lp(a) apheresis is an established treatment in Germany for secondary prevention of progressive cardiovascular disease. Statin-based lowering of LDL cholesterol and thrombocyte aggregation inhibitors still represent the basis of medical treatment. Target levels for LDL-cholesterol should be modified in patients with hyperlipoproteinemia (a).
Found 
Found 

Top-30

Journals

1
Pharmacogenomics
Pharmacogenomics, 1, 16.67%
Pharmacogenomics
1 publication, 16.67%
Atherosclerosis
Atherosclerosis, 1, 16.67%
Atherosclerosis
1 publication, 16.67%
Revista Portuguesa de Cardiologia, 1, 16.67%
Revista Portuguesa de Cardiologia
1 publication, 16.67%
Clinical and Translational Medicine
Clinical and Translational Medicine, 1, 16.67%
Clinical and Translational Medicine
1 publication, 16.67%
1

Publishers

1
2
3
Elsevier
Elsevier, 3, 50%
Elsevier
3 publications, 50%
Taylor & Francis
Taylor & Francis, 1, 16.67%
Taylor & Francis
1 publication, 16.67%
Sociedade Portuguesa De Cardiologia, 1, 16.67%
Sociedade Portuguesa De Cardiologia
1 publication, 16.67%
Wiley
Wiley, 1, 16.67%
Wiley
1 publication, 16.67%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
6
Share
Cite this
GOST |
Cite this
GOST Copy
Grützmacher P. et al. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a) // Clinical Research in Cardiology Supplements. 2017. Vol. 12. No. S1. pp. 22-26.
GOST all authors (up to 50) Copy
Grützmacher P., Öhm B., Szymczak S., Dorbath C., Brzoska M., Kleinert C. Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a) // Clinical Research in Cardiology Supplements. 2017. Vol. 12. No. S1. pp. 22-26.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1007/s11789-017-0090-3
UR - https://doi.org/10.1007/s11789-017-0090-3
TI - Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)
T2 - Clinical Research in Cardiology Supplements
AU - Grützmacher, P.
AU - Öhm, B
AU - Szymczak, S
AU - Dorbath, C.
AU - Brzoska, M.
AU - Kleinert, C.
PY - 2017
DA - 2017/02/23
PB - Springer Nature
SP - 22-26
IS - S1
VL - 12
PMID - 28233269
SN - 1861-0706
SN - 1861-0714
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2017_Grützmacher,
author = {P. Grützmacher and B Öhm and S Szymczak and C. Dorbath and M. Brzoska and C. Kleinert},
title = {Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a)},
journal = {Clinical Research in Cardiology Supplements},
year = {2017},
volume = {12},
publisher = {Springer Nature},
month = {feb},
url = {https://doi.org/10.1007/s11789-017-0090-3},
number = {S1},
pages = {22--26},
doi = {10.1007/s11789-017-0090-3}
}
MLA
Cite this
MLA Copy
Grützmacher, P., et al. “Primary and secondary prevention of cardiovascular disease in patients with hyperlipoproteinemia (a).” Clinical Research in Cardiology Supplements, vol. 12, no. S1, Feb. 2017, pp. 22-26. https://doi.org/10.1007/s11789-017-0090-3.